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ABSTRACT
In the last two decades Computer Aided Diagnostics (CAD) systems were developed to help radiologists analyze screening
mammograms. The benefits of current CAD technologies appear to be contradictory and they should be improved to be
ultimately considered useful. Since 2012 deep convolutional neural networks (CNN) have been a tremendous success in
image recognition, reaching human performance. These methods have greatly surpassed the traditional approaches, which are
similar to currently used CAD solutions. Deep CNN-s have the potential to revolutionize medical image analysis. We propose
a CAD system based on one of the most successful object detection frameworks, Faster R-CNN. The system detects and
classifies malignant or benign lesions on a mammogram without any human intervention. The proposed method sets the state
of the art classification performance on the public INbreast database, AUC = 0.95. The approach described here has achieved
the 2nd place in the Digital Mammography DREAM Challenge with AUC = 0.85. When used as a detector, the system reaches
high sensitivity with very few false positive marks per image on the INbreast dataset. Source code, the trained model and an
OsiriX plugin are published online at https://github.com/riblidezso/frcnn_cad .
Introduction
Screening mammography
Breast cancer is the most common cancer in women and it is the main cause of death from cancer among women in the world1.
Screening mammography was shown to reduce breast cancer mortality by 38–48% among participants2. In the EU 25 of the
28 member states are planning, piloting or implementing screening programs to diagnose and treat breast cancer in an early
stage3. During a standard mammographic screening examination, X-ray images are captured from 2 angles of each breast.
These images are inspected for malignant lesions by one or two experienced radiologists. Suspicious cases are called back for
further diagnostic evaluation.
Screening mammograms are evaluated by human readers. The reading process is monotonous, tiring, lengthy, costly
and most importantly prone to errors. Multiple studies have shown that 20-30% of the diagnosed cancers could be found
retrospectively on the previous negative screening exam by blinded reviewers4–9. The problem of missed cancers still persists
despite modern full field digital mammography (FFDM)4, 8. The sensitivity and specificity of screening mammography is
reported to be between 77-87% and 89-97% respectively. These metrics describe the average performance of readers, and
there is substantial variance in the performance of individual physicians, with reported false positive rates between 1-29%, and
sensitivities between 29-97%10–12. Double reading was found to improve the performance of mammographic evaluation and it
had been implemented in many countries13. Multiple reading can further improve diagnostic performance up to more than 10
readers, proving that there is room for improvement in mammogram evaluation beyond double reading14.
Computer-aided detection in mammographic screening
Computer-aided detection (CAD) solutions were developed to help radiologists in reading mammograms. These programs
usually analyze a mammogram and mark the suspicious regions, which should be reviewed by the radiologist15. The technology
was approved by FDA and had spread quickly. By 2008, in the US, 74% of all screening mammograms in the Medicare
population were interpreted with CAD, the cost of CAD usage is over $400 million a year.11.
The benefits of using CAD are controversial. Initially several studies have shown promising results with CAD6, 16–20. A
large clinical trial in the United Kingdom has shown that single reading with CAD assistance has similar performance to double
reading.21 However, in the last decade multiple studies concluded that currently used CAD technologies do not improve the
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performance of radiologists in everyday practice in the United States.11, 22, 23. These controversial results indicate that CAD
systems need to be improved before radiologists can ultimately benefit from using the technology in everyday practice.
Currently used CAD approaches are based on describing the X-ray image with meticulously designed hand crafted features,
and machine learning for classification on top of these features15, 24–27 . In the field of computer vision, since 2012, deep
convolutional neural networks (CNN) have significantly outperformed these traditional methods28. Deep CNN-s have reached
or even surpassed human performance in image classification and object detection.29. These models have tremendous potential
in medical image analysis. Several studies have attempted to apply Deep Learning to analyze mammograms27, 30–32, but the
problem is still far from being solved.
The Digital Mammography DREAM Challenge
The Digital Mammography DREAM Challenge (DM challenge)33, 34 asked participants to write algorithms which can predict
whether a breast in a screening mammography exam will be diagnosed with cancer. The dataset consisted of 86000 exams, with
no pixel level annotation, only a binary label indicating if breast cancer was diagnosed in the next 12 months after the exam.
Each side of the breasts were treated as a separate case that we will call breast-level prediction in this paper. The participants
had to upload their programs to a secure cloud platform, and they were not able to download or view the images, neither interact
with their program during training or testing. The DM challenge provided an excellent opportunity to compare the performance
of competing methods in a controlled and fair way instead of self-reported evaluations on different or proprietary datasets.
1 Material and methods
Data
Mammograms with pixel level annotations were needed to train a lesion detector and test the classification and localization
performance. We have trained the model on the public Digital Database for Screening Mammography (DDSM)35 and a dataset
from the Semmelweis University in Budapest, and tested it on the public INbreast36 dataset. The images used for training
contain either histologically proven cancers or benign lesions which were recalled for further examinations, but later turned out
to be nonmalignant. We expect that training with both kinds of lesions helps our model to find more lesions of interest, and
differentiate between malignant and benign examples.
The DDSM dataset contains 2620 digitized film-screen screening mammography exams, with pixel-level ground truth
annotation of lesions. Cancerous lesions have histological proof. We have only used the DDSM database for training our
model and not evaluating it. The quality of digitized film-screen mammograms is not as good as full field digital mammograms
therefore, evaluation on these cases is not relevant. We have converted the lossless jpeg images to png format, mapped the pixel
values to optical density using the calibration functions from the DDSM website, and rescaled the pixel values to the 0-255
range.
The dataset from the Department of Radiology at the Semmelweis University in Budapest, Hungary contains 847 FFDM
images of 214 exams from 174 patients, recorded with a Hologic LORAD Selenia device. Institutional board approval was
obtained for the dataset. This dataset was not available for the full period of the DM challenge, it is used only for improvement
in the second stage of the DM challenge, after the pixel level annotation by the authors.
The INbreast dataset contains 115 FFDM cases with pixel-level ground truth annotations, and histological proof for
cancers36. We have adapted the INbreast pixel level annotations to suit our testing scenario. We have ignored all benign
annotations, and converted the malignant lesion annotations to bounding boxes. We have excluded 8 exams which had other
findings, artifacts, previous surgeries or ambiguous pathological outcome. The images have low contrast therefore, we have
adjusted the window of the pixel levels. The pixel values were clipped to be minimum 500 pixel lower and maximum 800
pixels higher than the mode of the pixel value distribution (excluding the background) and were rescaled to the 0-255 range.
Data Availability
The DDSM dataset is available online at http://marathon.csee.usf.edu/Mammography/Database.html.
The INBreast dataset can be requested online at http://medicalresearch.inescporto.pt/breastresearch/
index.php/Get_INbreast_Database.
For the dataset from the Semmelweis university (http://semmelweis.hu/radiologia/) restrictions apply to the availability of these
data, which were used under special licence from Semmelweis University, and so are not publicly available. Data are however
available from the authors upon reasonable request and permission of the Semmelweis University.
Methods
The heart of our model is a state of the art object detection framework, Faster R-CNN37. Faster R-CNN is based on a
convolutional neural network with additional components for detecting, localizing and classifying objects in an image. Faster
R-CNN has a branch of convolutional layers, called Region Proposal Network (RPN), after the last convolutional layer of
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the original network, which is trained to detect and localize objects on the image, regardless of the class of the object. There
are default detection boxes with different sizes and aspect ratios in order to find objects with varying sizes and shapes. The
highest scoring default boxes are called the region proposals for the other branch of the network. The other branch of the neural
network evaluates the signal coming from each proposed region of the last convolutional layer, resampled to a fix size. Both
branches try to solve a classification task to detect the presence of objects and a bounding-box regression task in order to refine
the boundaries of the object present in the region. From the detected overlapping objects, the best predictions are selected using
non-maximum suppression. Further details about Faster R-CNN can be found in the original article37. An outline of the model
can be seen in Fig. 1.
Figure 1. The outline of the Faster R-CNN model for CAD in mammography.
The base CNN used in our model was a VGG16 network, which is 16 layer deep CNN38. The final layer can detect 2 kinds
of objects in the images, benign lesions or malignant lesions. The model outputs a bounding box for each detected lesion, and a
score, which reflects the confidence in the class of the lesion. To describe an image with one score, we take the maximum of the
scores of all malignant lesions detected in the image. For multiple images of the same breast, we take the average of the scores
of individual images. For the DM challenge we have trained 2 models using shuffled training datasets. When ensembling these
models, the score of an image was the average score of the individual models. This approach has been motivated by a previous
study on independent human readers, and it has proven reasonably effective, while simple and flexible14.
We have used the framework developed by the authors of Faster R-CNN37, which was built in the Caffe framework for deep
learning39. During training we optimized the object detection part and the classifier part of the model in the same time, this is
called the joint optimization37. We used backpropagation and stochastic gradient descent with weight decay. The initial model
used for training has been pretrained on 1.2 million images from the ImageNet dataset38.
We have found that higher resolution yields better results, therefore the mammograms were rescaled isotropically to longer
side smaller than 2100 pixels or shorter side smaller than 1700 pixels. This resolution is close to the maximum size which
fits in the memory of the graphics card used. The aspect ratio was selected to fit the regular aspect ratio of Hologic images.
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We applied vertical and horizontal flipping to augment the training dataset. Mammograms contain fewer object than ordinary
images, therefore negative proposals dominate minibatches. The Intersection over Union (IoU) threshold for foreground objects
in the region proposal network was relaxed from 0.7 to 0.5 to allow more positive samples in each minibatch. Relaxation of
positive examples is also supported by the fact that lesions on a mammogram have much less well defined boundaries than a
car or a dog on a tradiotional image. The IoU threshold of the final non maximum suppression (nms) was set to 0.1, because
mammograms represent a smaller and compressed 3D space compared to ordinary images, therefore overlapping detections
are expected to happen less often than in usual object detection. The model was trained for 40k iterations, this number was
previously found to be close to optimal by testing multiple models on the DM challenge training data. The model was trained
and evaluated on an Nvidia GTX 1080Ti graphics card. Our final entry in the DM challenge was an ensemble of 2 models.
Results
Cancer classification
We also evaluated the model’s performance on the public INbreast dataset with the receiver operating characteristics (ROC)
metric, Fig. 2. The INbreast dataset has many exams with only one laterality, therefore we have evaluated predictions for each
breast. The system achieved AUC = 0.95, (95 percentile interval: 0.91 to 0.98, estimated from 10000 bootstrap samples). To
our best knowledge this is the highest AUC score reported on the INbreast dataset with a fully automated system based on a
single model.
Figure 2. Classification performance. The solid blue line shows the ROC curve on the INbreast dataset on breast level, AUC
= 0.95, the dashed lines show the 95 percentile interval of the curve based on 10000 bootstrap samples.
FROC analysis
In order to test the model’s ability to detect and accurately localize malignant lesions, we evaluated the predictions on the
INbreast dataset using the Free-response ROC (FROC) curve40. The FROC curve shows the sensitivity (fraction of correctly
localized lesions) as a function of the number of false positive marks put on an image Fig. 3.
A detection was considered correct if the center of the proposed lesion fell inside a ground truth box. The same criteria is
generally used when measuring the performance of currently used CAD products24, 41, 42. The DM challenge dataset has no
lesion annotation, therefore we can not use it for an FROC analysis.
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Figure 3. FROC curve on the INbreast dataset. Sensitivity is calculated on a per lesion basis. The solid curve with squares
shows the results using all images, while the dashed lines show the 95 percentile interval from 10000 bootstrap samples.
Examples
To demonstrate the characteristics and errors of the detector, we have created a collection of correctly classified, false positive
and missed malignant lesions of the INbreast dataset, see in Fig. 4. The score threshold for the examples was defined at
sensitivity = 0.9 and 0.3 false positive marks per image.
After inspecting the false positive detections, we have found that most were benign masses or calcifications. Some of these
benign lesions were biopsy tested according to the case descriptions of the INbreast dataset. While 10% of the ground truth
malignant lesions were missed at this detection threshold, these were not completely overlooked by the model. With a score
threshold which corresponds to 3 false positive marks per image, all the lesions were correctly detected (see Fig. 3). Note that
the exact number of false positive and true positive detections slightly varies with with different samples of images, indicated
by the area in Fig. 3.
Discussion
We have proposed a Faster R-CNN based CAD approach, which achieved the 2nd position in the Digital Mammography
DREAM Challenge with an AUC = 0.85 score on the final validation dataset. The competition results have proved that the
method described in this article is one of the best approach for cancer classification in mammograms. Our method was the
only one of the top contenders in the DM challenge which is based on the detection of malignant lesions, and whole image
classification is just a trivial step from the detection task. We think that a lesion detector is clinically much more useful than
a simple classifier. A classifier only gives a single score for a case or breast, but it is not able to locate the cancer which is
essential for further diagnostic tests or treatment.
We have evaluated the model on the publicly available INbreast dataset. The system is able to detect 90% of the malignant
lesions in the INbreast dataset with only 0.3 false positive marks per image. It also sets the state of the art performance in
cancer classification on the publicly available INbreast dataset. The system uses the mammograms as the only input without
any annotation or user interaction.
An object detection framework developed to detect objects in ordinary images shows excellent performance. This result
indicates that lesion detection on mammograms is not very different from the regular object detection task. Therefore the
expensive, traditional CAD solutions, which have controversial efficiency, could be replaced with the recently developed,
potentially more accurate, deep learning based, open source object detection methods in the near future. The FROC analysis
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Figure 4. Detection examples: The yellow boxes show the lesion proposed by the model. The threshold for these detections
was selected to be at lesion detection sensitivity = 0.9. A: Correctly detected malignant lesions B: Missed malignant lesions C:
False positive detections, Courtesy of the Breast Research Group, INESC Porto, Portugal36
results suggest that the proposed model could be applied as a perception enhancer tool, which could help radiologists to detect
more cancers.
A limitation of our study comes from the small size of the publicly available pixel-level annotated dataset. While the
classification performance of the model has been evaluated on a large screening dataset, the detection performance could only
be evaluated on the small INbreast dataset.
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